Hyperhomocysteinemia in patients with acute porphyrias: a possible effect of ALAS1 modulation by siRNAm therapy and its control by vitamin supplementation

Paolo Ventura

Correspondence

Corresponding author at: Internal Medicine Unit, Department of Medical and Surgical Science for Children and Adults, Regional Reference Centre for Diagnosing and Management of Porphyrias, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico of Modena, Largo del Pozzo 71, 41124 Modena, Italy.

Affiliations

Internal Medicine Unit, Department of Medical and Surgical Science for Children and Adults,University of Modena e Reggio Emilia

Search for articles by this author

留言 (0)

沒有登入
gif